Physician profile

Vincent Guida

Internal Medicine · Barnegat, NJ

NPI 1285677427

$973.50

in general payments reported to CMS, 2019-2025

22 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$30.31

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $196.44 2019-2021
Janssen Pharmaceuticals, INC $122.07 2019
Lilly USA, LLC $111.40 2019-2021
Novo Nordisk INC $103.30 2019-2021
Amarin Pharma, INC. $58.53 2019-2020
Alnylam Pharmaceuticals INC. $45.21 2019
Eisai INC. $42.50 2020-2021
Mallinckrodt Enterprises LLC $38.11 2019
Exact Sciences Corporation $30.31 2024 Cologuard Collection Kit
Astellas Pharma US INC $27.57 2019-2021
Bayer Healthcare Pharmaceuticals INC. $27.24 2022
Dexcom, INC. $22.87 2021
Boston Scientific Corporation $19.12 2019
Daiichi Sankyo INC. $16.14 2021
Mallinckrodt Hospital Products INC. $16.14 2021
Show all 22 companies
CompanyGeneral paymentsYearsTop products
Harmony Biosciences LLC $15.12 2021
Abbvie INC. $14.95 2021
Merck Sharp & Dohme LLC $14.63 2019
Jazz Pharmaceuticals INC. $14.62 2021
Evoke Pharma, INC. $14.50 2021
W. L. Gore & Associates, INC. $11.64 2020
Teva Pharmaceuticals USA, INC. $11.09 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Vincent Guida

$973.50

in general payments reported 2019-2025

Years
2019-2024
Top company
Boehringer Ingelheim Pharmaceuticals, INC.

https://glasscript.com/doctor/13120/vincent-guida

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.